TREATMENT OF ACUTE MYELOCYTIC-LEUKEMIA WITH A DAUNORUBICIN-CYTARABINE-6 THIOGUANINE REGIMEN WITHOUT MAINTENANCE THERAPY

被引：4
|
作者：
FREUND, M [1 ]
POLIWODA, H [1 ]
BODENSTEIN, H [1 ]
EISERT, R [1 ]
机构：
[1] MED CTR,DEPT 4,MINDEN,FED REP GER
来源：
ONKOLOGIE | 1985年 / 8卷 / 03期
关键词：
D O I：
10.1159/000215643
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：150 / 152
页数：3
相关论文
共 50 条
  • [1] COMPARATIVE STUDY OF CYTOSINE-ARABINOSIDE THERAPY ALONE AND COMBINED WITH THIOGUANINE, MERCAPTOPURINE, OR DAUNORUBICIN IN ACUTE MYELOCYTIC-LEUKEMIA
    CAREY, RW
    RIBASMUNDO, M
    ELLISON, RR
    GLIDEWELL, O
    LEE, ST
    CUTTNER, J
    LEVY, RN
    SILVER, R
    BLOM, J
    HAURANI, F
    SPURR, CL
    HARLEY, JB
    KYLE, R
    MOON, JH
    EAGAN, RT
    HOLLAND, JH
    CANCER, 1975, 36 (05) : 1560 - 1566
  • [2] COMPARATIVE TRIAL OF DAUNORUBICIN, CYTOSINE-ARABINOSIDE, AND THIOGUANINE, AND A COMBINATION OF THE 3 AGENTS FOR THE TREATMENT OF ACUTE MYELOCYTIC-LEUKEMIA
    WIERNIK, PH
    GLIDEWELL, OJ
    HOAGLAND, HC
    BRUNNER, KW
    SPURR, CL
    CUTTNER, J
    SILVER, RT
    CAREY, RW
    DELDUCA, V
    KUNG, FH
    HOLLAND, JF
    MEDICAL AND PEDIATRIC ONCOLOGY, 1979, 6 (03): : 261 - 277
  • [3] DAT (DAUNORUBICIN, CYTARABINE, 6-THIOGUANINE) IN ACUTE MYELOID-LEUKEMIA
    REES, JKH
    HAYHOE, FGJ
    LANCET, 1978, 1 (8078): : 1360 - 1361
  • [4] CYTOSINE-ARABINOSIDE WITH DAUNORUBICIN OR ADRIAMYCIN FOR THERAPY OF ACUTE MYELOCYTIC-LEUKEMIA - A CALGB STUDY
    YATES, J
    GLIDEWELL, O
    WIERNIK, P
    COOPER, MR
    STEINBERG, D
    DOSIK, H
    LEVY, R
    HOAGLAND, C
    HENRY, P
    GOTTLIEB, A
    CORNELL, C
    BERENBERG, J
    HUTCHISON, JL
    RAICH, P
    NISSEN, N
    ELLISON, RR
    FRELICK, R
    JAMES, GW
    FALKSON, G
    SILVER, RT
    HAURANI, F
    GREEN, M
    HENDERSON, E
    LEONE, L
    HOLLAND, JF
    BLOOD, 1982, 60 (02) : 454 - 462
  • [5] CLINICAL AND CELL KINETIC DATA ON COMBINATION OF CYTOSINE-ARABINOSIDE WITH DAUNORUBICIN, IFOSFAMIDE, THIOGUANINE, AND VINCRISTINE FOR REMISSION INDUCTION AND MAINTENANCE IN PATIENTS WITH ACUTE MYELOCYTIC-LEUKEMIA
    BUCHNER, T
    KAMANABROO, D
    URBANITZ, D
    HIDDEMANN, W
    VANDELOO, J
    BLUT, 1978, 36 (06): : 371 - 376
  • [6] ACLARUBICIN IN THE TREATMENT OF DENOVO ACUTE MYELOCYTIC-LEUKEMIA
    LABAR, B
    NEMET, D
    MINIGO, H
    BOGDANIC, V
    JAKSIC, B
    MALESEVIC, M
    MRSIC, M
    BONE MARROW TRANSPLANTATION, 1989, 4 : 45 - 46
  • [7] A CALGB STUDY OF ADRIAMYCIN VS DAUNORUBICIN INDUCTION AND A 4 VS 8 WEEK MAINTENANCE IN ACUTE MYELOCYTIC-LEUKEMIA
    YATES, JW
    GLIDEWELL, O
    WIERNIK, P
    HOLLAND, JF
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 350 - 350
  • [8] A STUDY OF DAUNORUBICIN VS ADRIAMYCIN INDUCTION AND MONTHLY VS BIMONTHLY MAINTENANCE IN ACUTE MYELOCYTIC-LEUKEMIA FROM CALGB
    YATES, JW
    GLIDEWELL, O
    WIERNIK, P
    HOLLAND, JF
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 487 - 487
  • [9] Cytarabine and daunorubicin for the treatment of acute myeloid leukemia
    Murphy, Tracy
    Yee, Karen W. L.
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (16) : 1765 - 1780
  • [10] ACUTE MYELOCYTIC-LEUKEMIA FOLLOWING PROLONGED STREPTOZOTOCIN THERAPY
    GREEN, MR
    ANDERSON, RE
    CANCER, 1981, 47 (08) : 1963 - 1965
12345